Search

Search Results
Results 341 - 350 of 353 for Acute rejection
  • Methoblastin Blister
    Drug - 21 Feb 2025
    Consumer Medicine Information (CMI) about Methoblastin Blister intended for persons living in Australia.
  • Litfulo
    Drug - 27 Aug 2024
    Consumer Medicine Information (CMI) about Litfulo intended for persons living in Australia.
  • Prograf and Advagraf XL
    Drug - 5 Jun 2024
    Consumer Medicine Information (CMI) about Prograf and Advagraf XL intended for persons living in Australia.
  • Vttack
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Vttack intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Coralan
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Coralan (ivabradine 5mg & 7.5mg film coated tablets) intended for persons living in Australia.
  • Lumakras
    Drug - 14 Jun 2022
    Consumer Medicine Information (CMI) about Lumakras intended for persons living in Australia.
  • Zykadia
    Drug - 5 Apr 2022
    Consumer Medicine Information (CMI) about Zykadia intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback